For the fiscal year, which began in July for Erlanger, the health system has a total of $6.4 million in operations losses, according to the report. Erlanger administrators had projected it would have a surplus of nearly $4 million by the end of November.
Admissions were 9.1 percent higher than Erlanger witnessed last November, and physician outpatient visits increased 27.8 percent. Interim CEO Charlesetta Woodard-Thompson declined to comment about the system’s finances.
Related Articles on Erlanger Health System:
Erlanger Health System in Tennessee Promotes COO to Interim CEO
Tennessee’s Erlanger CEO Jim Brexler Announces Retirement Plans
Erlanger Health System’s Relationships With Cardiologists Under Investigation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
